0001209191-21-013508.txt : 20210223
0001209191-21-013508.hdr.sgml : 20210223
20210223201349
ACCESSION NUMBER: 0001209191-21-013508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nau Jeffrey
CENTRAL INDEX KEY: 0001791159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39112
FILM NUMBER: 21668014
MAIL ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oyster Point Pharma, Inc.
CENTRAL INDEX KEY: 0001720725
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 811030955
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 382-9032
MAIL ADDRESS:
STREET 1: 202 CARNEGIE CENTER
STREET 2: SUITE 109
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-19
0
0001720725
Oyster Point Pharma, Inc.
OYST
0001791159
Nau Jeffrey
C/O OYSTER POINT PHARMA, INC.
202 CARNEGIE CENTER, SUITE 109
PRINCETON
NJ
08540
1
1
0
0
President and CEO
Common Stock
2021-02-19
4
M
0
10000
1.02
A
40898
D
Common Stock
1000
I
See Footnote
Employee Stock Option (Right to Buy)
1.02
2021-02-19
4
M
0
10000
0.00
D
2027-11-10
Common Stock
10000
504774
D
These shares are held by the Reporting Person's spouse.
This option was granted on November 10, 2017 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One forty-eighth of the total number of shares subject to the original option vested on December 1, 2017, and one forty-eighth of the remaining shares vested, and continue to vest, monthly thereafter, subject to continued service to the Issuer through each such vesting date. The award is subject to vesting acceleration under certain circumstances.
/s/ Brandon Fenn, Attorney-in-Fact
2021-02-23